Subject Material. 15.1. Subject Material means any biologic material of human origin including, without limitation, tissues, blood, plasma, urine, spinal fluid, or other fluids derived from the Study subjects in accordance with and pursuant to the Protocol (“Subject Material”). 15.2. Institution agrees to make the Subject Material available to the Sponsor in accordance with the Protocol for the purposes of the Study. The Subject Material may be used by the Sponsor, central lab, or other contracted party only as allowed by the Study subject’s informed consent form or pertinent institutional review board(s). Sponsor agrees that any use of Subject Materials, other than as allowed by the Study subject’s informed consent form, will require additional IRB review and approval.
Appears in 7 contracts
Samples: Clinical Trial Agreement (GT Biopharma, Inc.), Clinical Trial Agreement, Accelerated Clinical Trial Agreement
Subject Material. 15.1. Subject Material means any biologic material of human origin including, without limitation, tissues, blood, plasma, urine, spinal fluid, or other fluids derived from the Study subjects in accordance with and pursuant to the Protocol (“Subject Material”).
15.2. Institution agrees to make the Subject Material available to the Sponsor in accordance with the Protocol for the purposes of the Study. The Subject Material may be used by the Sponsor, central lab, or other contracted party only as allowed by the Study subject’s informed consent form or pertinent institutional review board(s). Sponsor agrees that any Sponsor’s use of Subject Materials, other than as allowed by the Study subject’s informed consent form, will require additional IRB review and approval.
Appears in 5 contracts
Samples: Accelerated Clinical Trial Agreement (BriaCell Therapeutics Corp.), Accelerated Clinical Trial Agreement (BriaCell Therapeutics Corp.), Accelerated Clinical Trial Agreement (BriaCell Therapeutics Corp.)
Subject Material. 15.1. Subject Material means any biologic material of human origin including, without limitation, tissues, blood, plasma, urine, spinal fluid, or other fluids derived from the Study subjects in accordance with and pursuant to the Protocol (“Subject Material”).
15.2. Institution agrees to make the Subject Material available to the Sponsor in accordance with the Protocol for the purposes of the Study. The Subject Material may be used by the Sponsor, central lab, or other contracted party only as allowed by the Study subject’s informed consent form or pertinent institutional review board(s). Sponsor Xxxxxxx agrees that any use of Subject Materials, other than as allowed by the Study subject’s informed consent form, will require additional IRB review and approval.
Appears in 4 contracts
Samples: Clinical Trial Agreement, Clinical Trial Agreement, Accelerated Clinical Trial Agreement
Subject Material. 15.1. Subject Material means any biologic material of human origin including, without limitation, tissues, blood, plasma, urine, spinal fluid, or other fluids derived from the Study subjects in accordance with and pursuant to as required by the Protocol (“Subject Material”).
15.2. Institution agrees to make the Subject Material available to the Sponsor in accordance with the Protocol for the purposes of the Study. The Subject Material may be used by the Sponsor, central lab, or other contracted party only as allowed by the Study subject’s informed consent form or pertinent institutional review board(s)and/or research authorization. Sponsor Xxxxxxx agrees that any use of Subject Materials, other than as allowed by the Study subject’s informed consent formform and/or research authorization, will require additional IRB Institutional review and approval.
Appears in 3 contracts
Samples: Accelerated Clinical Trial Agreement, Accelerated Clinical Trial Agreement, Accelerated Clinical Trial Agreement
Subject Material. 15.1. Subject Material means any biologic material of human origin including, without limitation, tissues, blood, plasma, urine, spinal fluid, or other fluids derived from the Study subjects in accordance with and pursuant to the Protocol (“Subject Material”).
15.2. Institution agrees and Principal Investigator agree to make the Subject Material available to the Sponsor in accordance with the Protocol for the purposes of the Study. The Subject Material may be used by the Sponsor, central lab, or other contracted party only as allowed by the Study subject’s informed consent form or pertinent institutional review board(s). Sponsor agrees that any Sponsor’s use of Subject Materials, other than as allowed by the Study subject’s informed consent form, will require additional IRB review and approval.
Appears in 2 contracts
Samples: Clinical Trial Agreement (BriaCell Therapeutics Corp.), Clinical Trial Agreement (BriaCell Therapeutics Corp.)
Subject Material. 15.1. 15.1 Subject Material means any biologic material of human origin including, without limitation, tissues, blood, plasma, urine, spinal fluid, or other fluids derived from the Study subjects in accordance with and pursuant to the Protocol (“Subject Material”).
15.2. 15.2 Institution agrees to make the Subject Material available to the Sponsor in accordance with the Protocol for the purposes of the Study. The Subject Material may be used by the Sponsor, central lab, or other contracted party only as allowed by the Study subject’s informed consent form or pertinent institutional review board(s). Sponsor agrees that any use of Subject Materials, other than as allowed by the Study subject’s informed consent form, will require additional IRB review and approval.
Appears in 2 contracts
Samples: Clinical Trial Agreement, Clinical Trial Agreement (Magenta Therapeutics, Inc.)
Subject Material. 15.1. Subject Material means any biologic material of human origin including, without limitation, tissues, blood, plasma, urine, spinal fluid, or other fluids derived from the Study subjects in accordance with and pursuant to as required by the Protocol (“Subject Material”).
15.2. Institution agrees to make the Subject Material available to the Sponsor in accordance with the Protocol for the purposes of the Study. The Subject Material may be used by the Sponsor, central lab, or other contracted party only as allowed by the Study subject’s informed consent form or pertinent institutional review board(s)and/or research authorization. Sponsor agrees that any use of Subject Materials, other than as allowed by the Study subject’s informed consent formform and/or research authorization, will require additional IRB Institutional review and approval.
Appears in 2 contracts
Samples: Accelerated Clinical Trial Agreement, Accelerated Clinical Trial Agreement
Subject Material. 15.1. Subject Material means any biologic material of human origin including, without limitation, tissues, blood, plasma, urine, spinal fluid, or other fluids derived from the Study subjects in accordance with and pursuant to the Protocol (“Subject Material”).
15.2. Institution agrees and Clinic agree to make the Subject Material available to the Sponsor in accordance with the Protocol for the purposes of the Study. The Subject Material may be used by the Sponsor, central lab, or other contracted party only as allowed by the Study subject’s informed consent form or pertinent institutional review board(s). Sponsor agrees that any Sponsor’s use of Subject Materials, other than as allowed by the Study subject’s informed consent form, will require additional IRB review and approval.
Appears in 1 contract
Samples: Accelerated Clinical Trial Agreement (BriaCell Therapeutics Corp.)